XNCR

Xencor Inc.

Price

$27.52

return (12m)

262.58%

p/e

-10.61

p/bv

3.44

DIVIDEND YIELD

0.00%

XNCR price

Xencor

If you had invested

exposure

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Return on Investment XNCR

1 month

3 months

1 year

2 years

5 years

10 years

return

1 month

36.41%

3 months

144.19%

1 year

262.58%

2 years

63.23%

5 years

-13.30%

10 years

0.00%

Asset Comparator

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

Fundamentals XNCR

Valuation

P/E

-10.61

Sector -4.38

Industry -4.38

P/BV

3.44

Sector 2.02

Industry 2.02

P/Revenue (PSR)

16.51

Sector -4.40

Industry -4.40

EV/EBITDA

-111.62

Sector -263.09

Industry -263.09

EV/EBIT

-92.92

Sector -702.90

Industry -702.90

P/EBITDA

-14.02

Sector -4.39

Industry -4.39

P/EBIT

-12.95

Sector -4.73

Industry -4.73

P/Total Assets

2.39

Sector 1.49

Industry 1.49

P/Net Current Assets

5.75

Sector -11.70

Industry -11.70

P/Working Capital

3.93

Sector -3.19

Industry -3.19

EPS

-2.15

Sector -2.14

Industry -2.14

BVPS

6.62

Sector 1.85

Industry 1.85

Efficiency

Gross Margin

100.00%

Sector 36.74%

Industry 36.74%

EBITDA Margin

-23.68%

Sector -16,244.81%

Industry -16,244.81%

EBIT Margin

-28.45%

Sector -4,202,541.34%

Industry -4,202,541.34%

Operating Margin

-100.00%

Sector -38.22%

Industry -38.22%

Net Profit Margins

-100.00%

Sector -39.69%

Industry -39.69%

Asset Turnover

0.07

Sector 0.03

Industry 0.03

Profitability

ROE

-32.46%

Sector -65.14%

Industry -65.14%

ROA

-22.53%

Sector -65.53%

Industry -65.53%

ROIC

-56.81%

Sector -2,103.35%

Industry -2,103.35%

Dividends

Dividend yield

0.00%

Sector -

Industry -

Payout

Sector -

Industry -

Debt

Current Ratio

6.39

Sector 2.90

Industry 2.90

Net Debt / EBITDA

31.24

Sector -6.07

Industry -6.07

Net Debt / EBIT

26.01

Sector -8.26

Industry -8.26

Net Debt / Equity

-0.75

Sector -1.07

Industry -1.07

Gross Debt / Equity

0.15

Sector -0.05

Industry -0.05

Equity/Assets

0.69

Sector 0.41

Industry 0.41

Liabilities/Assets

0.31

Sector 0.39

Industry 0.39

Growth

5Y Revenue CAGR

-17.53%

Sector -

Industry -

5Y Earnings CAGR

0.00%

Sector -

Industry -

Fundamentals XNCR

DRAG THE FRAME TO SEE MORE DATA

Assets	Price (US$)	Return 12m	DY	P/E	P/BV	ROE	Net Profit Margins
XNCR Xencor Inc.	$27.52	252.37%	0.00%	-10.61	3.44	-32.46%	-100.00%
JNJ Johnson & Johnson	$273.41	58.46%	2.02%	29.66	7.34	24.76%	21.48%
PFE Pfizer Inc.	$28.24	21.45%	6.54%	34.62	1.75	5.07%	6.80%
ABBV AbbVie Inc.	$265.97	33.11%	2.73%	70.02	-74.53	-106.44%	9.81%
NVO Novo Nordisk A/S	$46.48	-9.14%	4.09%	11.13	5.91	53.11%	35.32%
MRK Merck & Co. Inc.	$152.20	87.95%	2.45%	106.68	8.06	7.56%	4.77%
AZN AstraZeneca PLC	$164.95	4.92%	2.07%	22.98	4.77	20.74%	17.02%
BMY Bristol-Myers Squibb Company	$67.61	46.95%	3.93%	14.06	5.85	41.59%	18.87%
ZTS Zoetis Inc.	$76.68	-48.52%	2.77%	11.89	9.88	83.10%	27.49%
REGN Regeneron Pharmaceuticals Inc.	$840.84	43.05%	0.45%	19.09	2.61	13.65%	27.86%
AMGN Amgen Inc.	$442.36	55.11%	2.39%	25.30	18.93	74.80%	22.95%
HALO Halozyme Therapeutics Inc.	$107.62	56.06%	0.00%	27.82	80.17	288.14%	24.86%
MCK McKesson Corporation	$853.71	27.85%	0.38%	22.42	-79.15	-352.96%	1.12%
VRTX Vertex Pharmaceuticals Incorporated	$552.06	41.60%	0.00%	29.26	6.36	21.76%	35.00%
CAH Cardinal Health Inc.	$234.85	58.85%	0.88%	31.61	-19.89	-62.92%	0.67%
HRMY Harmony Biosciences Holdings Inc.	$39.93	9.67%	0.00%	12.18	2.21	18.14%	18.89%
BIIB Biogen Inc.	$221.56	63.02%	0.00%	37.04	1.64	4.43%	8.32%

Stock vs Indice Comparison Tool

If you had invested

years ago

ago, you would now have *

ago, you would now have:

*This calculation reflects price variation only.

XNCR Historical Dividends

current DY: 0.00%

5-year average DY: 0.00%

no dividend paid in the period.

ABOUT Xencor

Xencor Inc.

Average Investor10 user rating

4.0 (0 people)

United States

29 years

Founded: 1997

2013

Time since IPO - 13 years

166

Employees

Xencor Inc. (United States) is listed on the Nasdaq and has a market capitalization of $1.73 billion, with shareholders equity totaling $503.23 million.

The company employs approximately 166 people and operates in the Health Care sector, within the Biotechnology industry.

Over the past 12 months, Xencor Inc. reported $104.98 million in revenue, generating net income of $-163.33 million.

Key financial metrics include a P/E ratio of -10.61, a price-to-book (P/B) ratio of 3.44, and a trailing twelve-month dividend yield of 0.00%.

The company trades under the ticker XNCR.

Market cap

$1.73 billion

Net worth

$503.23 million

$503,230,000.00

Assets

$724.96 million

$724,960,000.00

Total Shares Outstanding

76.00 million

76,000,000

Average Daily Trading Volume

$1.04 million

$1,037,438.04

Sector

Health Care

Industry

Biotechnology

XNCR

XNCR revenue and profits

Financial Results XNCR

DRAG THE FRAME TO SEE MORE DATA

XNCR cash flow

DRAG THE FRAME TO SEE MORE DATA

Discover more assets

BFRA - Biofrontera

$- -0,00% (12M)

P/E

0.00

0.00%

ROE

-893.55%

P/BV

0.00

MCK - McKesson

$853.71 22,07% (12M)

P/E

22.42

0.38%

ROE

-352.96%

P/BV

-79.15

CAH - Cardinal Health

$234.85 55,51% (12M)

P/E

31.61

0.88%

ROE

-62.92%

P/BV

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12M)

P/E

29.66

2.02%

ROE

24.76%

P/BV

7.34

ABBV - AbbVie

$265.97 31,23% (12M)

P/E

70.02

2.73%

ROE

-106.44%

P/BV

-74.53

MRK - Merck & Co.

$152.20 86,97% (12M)

P/E

106.68

2.45%

ROE

7.56%

P/BV

8.06

AZN - AstraZeneca

$164.95 5,00% (12M)

P/E

22.98

2.07%

ROE

20.74%

P/BV

4.77

PFE - Pfizer

$28.24 21,16% (12M)

P/E

34.62

6.54%

ROE

5.07%

P/BV

1.75

BFRA - Biofrontera

$- -0,00% (12 M)

P/L

0.00

0.00%

ROE

-893.55%

P/VP

0.00

MCK - McKesson

$853.71 22,07% (12 M)

P/L

22.42

0.38%

ROE

-352.96%

P/VP

-79.15

CAH - Cardinal Health

$234.85 55,51% (12 M)

P/L

31.61

0.88%

ROE

-62.92%

P/VP

-19.89

JNJ - Johnson & Johnson

$273.41 57,54% (12 M)

P/L

29.66

2.02%

ROE

24.76%

P/VP

7.34

ABBV - AbbVie

$265.97 31,23% (12 M)

P/L

70.02

2.73%

ROE

-106.44%

P/VP

-74.53

MRK - Merck & Co.

$152.20 86,97% (12 M)

P/L

106.68

2.45%

ROE

7.56%

P/VP

8.06

AZN - AstraZeneca

$164.95 5,00% (12 M)

P/L

22.98

2.07%

ROE

20.74%

P/VP

4.77

PFE - Pfizer

$28.24 21,16% (12 M)

P/L

34.62

6.54%

ROE

5.07%

P/VP

1.75

Frequently Asked Questions

What is the price of Xencor (XNCR) today?

A cotação de Xencor (XNCR) hoje está em US$ 27.52, com uma variação de 262.58% em relação ao último ano. A cotação de Xencor (XNCR) iniciou o ano negociando na casa dos US$ 15.31 e hoje está em US$ 27.52. Acompanhe o gráfico de cotação em tempo real, a cotação histórica de Xencor (XNCR) e dados de ações do Ibovespa e mercados internacionais.

Quando Xencor (XNCR) paga dividendos?

Xencor (XNCR) não distribuiu dividendos no último ano.

Is Xencor (XNCR) a good investment?

Atualmente, Xencor (XNCR) está cotada a US$ 27.52, com um P/L de -10.61, representando um desvio de -1,367% em relação ao seu P/L médio histórico. No último ano, a ação apresentou uma variação de 262.58 em sua cotação e distribuiu US$ 0.00 em dividendos, resultando em um Dividend Yield de 0.00%. O retorno total do acionista foi de 262.58%.

Investors should keep in mind that past performance does not guarantee future results. This information is provided for educational purposes only and should not be considered investment advice.

How can I buy Xencor (XNCR) stock?

Investir em ações de Xencor (XNCR) pode ser feito de duas formas: comprando a stock uma empresa estrangeira e é atrelado ao dólar.

How much would 100 shares of Xencor (XNCR) yield today?

A rentabilidade de Xencor (XNCR) foi de 36.41% no último mês, 262.58% no último ano e -13.30% nos últimos 5 anos (já considerando valorização e dividendos).

Nos últimos 12 meses, a empresa pagou um total de US$ 0.00 em dividendos, um Dividend Yield de 0.00%.

Se você quisesse comprar 100 ações de Xencor (XNCR) hoje, o investimento total seria de US$ 2,752.00, com base na cotação atual de US$ 27.52.

Based on historical performance, the investment would have grown to approximately:

Em 1 ano: US$ 9,978.20
Em 5 anos: US$ 2,385.98
Em 10 anos: US$ 2,752.00

Past performance does not guarantee future results. This content is for informational purposes only and should not be considered investment advice.

XNCR

Xencor Inc.

Price

return (12m)

p/e

p/bv

DIVIDEND YIELD

Return on Investment XNCR

Valuation

Efficiency

Profitability

Dividends

Debt

Growth

COMPARING XNCR WITH OTHER STOCK

current DY: 0.00%

5-year average DY: 0.00%

ABOUT Xencor

Xencor Inc.

United States

29 years

2013

166

PROFIT X PRICE XNCR

Financial Results XNCR

XNCR cash flow

Asset, Revenue and Profit Growth - XNCR

XNCR balance sheet

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

BFRA - Biofrontera

MCK - McKesson

CAH - Cardinal Health

JNJ - Johnson & Johnson

ABBV - AbbVie

MRK - Merck & Co.

AZN - AstraZeneca

PFE - Pfizer

Frequently Asked Questions